7.57
2.44%
0.18
Finanzdaten der Biocryst Pharmaceuticals Inc-Aktie (BCRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
0.69%
92.76
|
93.40 | 86.74 | 82.49 | 68.78 |
Cost Of Revenue |
18.75%
1.265
|
1.557 | 1.099 | 0.894 | 0.931 |
Gross Profit |
0.38%
91.50
|
91.84 | 85.64 | 81.60 | 67.85 |
Operating Expenses
|
21.21%
105.98
|
134.51 | 97.56 | 102.30 | 96.26 |
Interest Income/Expense |
0.31%
24.51
|
24.58 | 27.34 | 28.91 | 27.40 |
Benefits Costs and Expenses |
18.39%
127.78
|
156.56 | 122.56 | 157.08 | 121.44 |
Costs And Expenses |
21.18%
107.25
|
136.07 | 98.66 | 103.19 | 97.19 |
Operating Income/Loss |
66.05%
-14.49
|
-42.67 | -11.92 | -20.70 | -28.41 |
Income/Loss From Continuing Operations Before Tax |
44.56%
-35.01
|
-63.16 | -35.82 | -74.59 | -52.66 |
Income Tax Expense/Benefit |
125.51%
0.365
|
-1.431 | 0.33 | 0.74 | 0.671 |
Income/Loss From Continuing Operations After Tax |
42.69%
-35.38
|
-61.73 | -36.15 | -75.33 | -53.33 |
Net Income/Loss
|
42.69%
-35.38
|
-61.73 | -36.15 | -75.33 | -53.33 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
6,541%
206.06
|
3.103 | 189.64 | 189.12 | 188.51 |
Diluted Average Shares |
6,541%
206.06
|
3.103 | 189.64 | 189.12 | 188.51 |
Basic Earnings Per Share |
45.16%
-0.17
|
-0.31 | -0.19 | -0.40 | -0.28 |
Diluted Earnings Per Share |
45.16%
-0.17
|
-0.31 | -0.19 | -0.40 | -0.28 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):